BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35247754)

  • 1. Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
    Hua D; Wu X
    Eur J Med Chem; 2022 Apr; 233():114227. PubMed ID: 35247754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Status of SUMOylation Inhibitors.
    Brackett CM; Blagg BSJ
    Curr Med Chem; 2021; 28(20):3892-3912. PubMed ID: 32778019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the Discovery of Small Molecule Modulators of DeSUMOylation.
    Chen S; Dong D; Xin W; Zhou H
    Curr Issues Mol Biol; 2020; 35():17-34. PubMed ID: 31422931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO-SIM interactions: From structure to biological functions.
    Lascorz J; Codina-Fabra J; Reverter D; Torres-Rosell J
    Semin Cell Dev Biol; 2022 Dec; 132():193-202. PubMed ID: 34840078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-Molecule Inhibitors Targeting Protein SUMOylation as Novel Anticancer Compounds.
    Yang Y; Xia Z; Wang X; Zhao X; Sheng Z; Ye Y; He G; Zhou L; Zhu H; Xu N; Liang S
    Mol Pharmacol; 2018 Aug; 94(2):885-894. PubMed ID: 29784649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms, regulation and consequences of protein SUMOylation.
    Wilkinson KA; Henley JM
    Biochem J; 2010 May; 428(2):133-45. PubMed ID: 20462400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a Dual SENP1 and SENP2 Inhibitor.
    Brand M; Bommeli EB; Rütimann M; Lindenmann U; Riedl R
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts.
    Celen AB; Sahin U
    FEBS J; 2020 Aug; 287(15):3110-3140. PubMed ID: 32255256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The post-translational modification, SUMOylation, and cancer (Review).
    Han ZJ; Feng YH; Gu BH; Li YM; Chen H
    Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMOylation in Skeletal Development, Homeostasis, and Disease.
    Liu H; Craig SEL; Molchanov V; Floramo JS; Zhao Y; Yang T
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The
    Bea A; Kröber-Boncardo C; Sandhu M; Brinker C; Clos J
    Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33066659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
    Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
    J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms in SUMO conjugation.
    Varejão N; Lascorz J; Li Y; Reverter D
    Biochem Soc Trans; 2020 Feb; 48(1):123-135. PubMed ID: 31872228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of post-translational modification in breast cancer treatment.
    Heo KS
    BMB Rep; 2019 Feb; 52(2):113-118. PubMed ID: 30638182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Role of SUMO and SUMOylation in the Pathogenesis of Diabetes Mellitus.
    Sadeghi M; Dehnavi S; Shohan M; Jamialahmadi T; Sathyapalan T; Sahebkar A
    Curr Med Chem; 2023; 30(14):1623-1637. PubMed ID: 35980066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the SUMOylated landscape.
    Eifler K; Vertegaal AC
    FEBS J; 2015 Oct; 282(19):3669-80. PubMed ID: 26185901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO--a post-translational modification with therapeutic potential?
    Woo CH; Abe J
    Curr Opin Pharmacol; 2010 Apr; 10(2):146-55. PubMed ID: 20079693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Protein Abundance and Localization Inferred from Sites of Alternative Modification by Ubiquitin and SUMO.
    Ulman A; Levin T; Dassa B; Javitt A; Kacen A; Shmueli MD; Eisenberg-Lerner A; Sheban D; Fishllevich S; Levy ED; Merbl Y
    J Mol Biol; 2021 Oct; 433(21):167219. PubMed ID: 34464654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SUMO components in rheumatoid arthritis.
    Wu Q; Jiang Y; You C
    Rheumatology (Oxford); 2022 Nov; 61(12):4619-4630. PubMed ID: 35595244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?
    Cheng X; Yang W; Lin W; Mei F
    Pharmacol Rev; 2023 Sep; 75(5):979-1006. PubMed ID: 37137717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.